Holen Sie sich die Stockscreener-App
74.25
0.99%
0.73
Handel nachbörslich:
74.48
0.23
+0.31%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$73.52
Offen:
$74.33
24-Stunden-Volumen:
1.16M
Relative Volume:
0.54
Marktkapitalisierung:
$35.89B
Einnahmen:
$10.63B
Nettoeinkommen (Verlust:
$819.00M
KGV:
44.79
EPS:
1.6577
Netto-Cashflow:
$1.59B
1W Leistung:
+3.40%
1M Leistung:
+11.05%
6M Leistung:
-6.25%
1J Leistung:
-14.45%
1-Tages-Spanne:
$74.02
$74.92
1-Wochen-Bereich:
$71.15
$76.20
52-Wochen-Spanne:
$61.84
$90.41
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Herabstufung | Stifel | Buy → Hold |
| 2025-12-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
Alcon stock trades steady as 2026 earnings and eye care demand support valuation - AD HOC NEWS
Alcon: Historical Growth Significantly Understates Potential (ALC) - Seeking Alpha
Alcon stock holds near highs after a 2026 profit lift - AD HOC NEWS
Alcon terminates PowerVision IOL programs, takes $402M write-off - MassDevice
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery? - Yahoo Finance
Bill Ackman’s Pershing Square Just Bought Netflix and 5 Other Stocks. Here’s What Investors Need to Know. - The Motley Fool
Ackman unveils six new investments including Netflix, Visa, Mastercard in portfolio overhaul - Reuters
Resilient Alcon stock holds near $73 as analysts diverge after Q2 strength - AD HOC NEWS
BNP Paribas Downgrades Alcon to Neutral, Cuts PT - marketscreener.com
Resilient Alcon stock holds near recent highs after margin outlook upgrade - AD HOC NEWS
Alcon’s Strong Q2 Left Bernstein More Confident On 2026 - Finimize
Bernstein Updates Alcon Estimates, Price Target After 'Strong' Commercial Execution in Q2 - marketscreener.com
BNP Paribas Exane cuts Alcon stock rating on competitive pressure By Investing.com - Investing.com Australia
BNP Paribas Exane cuts Alcon stock rating on competitive pressure - Investing.com
Alcon Steps Away from PowerVision IOL Program - mddionline.com
Tariff refund boosts Alcon’s second quarter results - WFMZ.com
Bernstein raises Alcon stock price target on product launches By Investing.com - Investing.com South Africa
Bernstein raises Alcon stock price target on product launches - Investing.com
ALC Maintained by Mizuho -- Price Target Raised to $85.00 - GuruFocus
Alcon’s New-Product Wave Carries Q2 As It Walks Away From Accommodating IOL Bet - insights.citeline.com
Alcon stock slips as profit reset follows stronger Q2 growth - AD HOC NEWS
Mizuho raises Alcon stock price target to $85 on new products - Investing.com
Key facts: Alcon AG (ALC) Q2 sales +7%; Q3 gross margin to rise - TradingView
BTIG reiterates Buy on Alcon stock after Q2 results beat margins - Investing.com UK
Alcon Inc. (ALC) Stock Forecasts - Yahoo Finance
Alcon Q2 Sales Rise on Strength in Vision Care, Surgical Segments - VisionMonday.com
Alcon (SWX:ALC) Stock Grapples With Profit Reset Despite Stronger Sales - simplywall.st
A broken promise does not deter Alcon’s ambitions - Agefi.com
Alcon Inc (ALC) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Strategic Pivots ... - Yahoo Finance Singapore
Swiss Stocks Dip As Alcon Jumps And UBS Rules Wait - Finimize
Alcon Earnings: Unity Performance Continues to Impress and Makes Up for Soft Lens Market - Morningstar
Alcon Releases Q2 2026 Financial Results - AlphaStreet
ALC Maintains Buy Rating by Needham -- Price Target Raises to $9 - GuruFocus
New Launches and Pipeline Investments Support Alcon's Market Leadership and Strong Fundamentals - Morningstar
How Is Alcon (NYSE:ALC) Tracking on the NYSE Composite Today? - Kalkine Media
Eye care company Alcon raises margin outlook, shares jump - AOL.com
Swiss Market Index Blinks Red; Alcon Shares Rise - marketscreener.com
Alcon Stock Jumps 4% as Tariff Relief Lifts Profit Target - Yahoo Finance
AlphaValue sees clear skies ahead for Alcon - marketscreener.com
AlphaValue says the outlook is clear for Alcon - marketscreener.com
Alcon: $402 Million Charge Follows PowerVision IOL Shutdown After Unpredictable Post-Surgical Outcomes - Pulse 2.0
Alcon Q2 2026 slides: 7% growth, margin gains despite PowerVision hit - Investing.com
Earnings call transcript: Alcon tops Q2 2026 estimates and lifts outlook - Investing.com
Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs - TradingView
Alcon : Second-Quarter 2026 Earnings Call Regulatory Filing - marketscreener.com
Alcon CFO On CallHigher Gross Margin In Q3 Due To Tariff Refunds - TradingView
Alcon Lifted Its 2026 Profit Outlook On Milder Tariffs - Finimize
Alcon Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Alcon Inc. (ALC) Q2 FY2026 earnings call transcript - Yahoo Finance
Alcon raises 2026 earnings growth outlook on positive Q2 results - Yahoo Finance
Alcon Lifts 2026 Outlook Amid Higher First-half Sales, Lower Tariff Impact Forecast - marketscreener.com
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.01%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):